# Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage

Study · id `cardio:ct-nct06711302` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06711302](<https://clinicaltrials.gov/study/NCT06711302>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06711302

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT06711302. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-01 (anticipated); primary completion 2026-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT06711302, source copy `cardio:ctgov-nct06711302-2025-07-10`, retrieved 2026-10-26)
- Planned start: 2025-07-01 (anticipated) (ClinicalTrials.gov record NCT06711302, source copy `cardio:ctgov-nct06711302-2025-07-10`, retrieved 2026-10-26)
- Primary completion: 2026-01-01 (anticipated) (ClinicalTrials.gov record NCT06711302, source copy `cardio:ctgov-nct06711302-2025-07-10`, retrieved 2026-10-26)
- Completion: 2026-04-01 (anticipated) (ClinicalTrials.gov record NCT06711302, source copy `cardio:ctgov-nct06711302-2025-07-10`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06711302, source copy `cardio:ctgov-nct06711302-2025-07-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06711302-2025-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage
- Acronym: REPAIR
- Condition: Subarachnoid Hemorrhage
- Condition: Cerebrovascular Disorders
- Condition: Brain Diseases
- Condition: Stroke
- Condition: Cardiovascular Diseases
- Condition: Vascular Diseases
- Condition: Nervous System Diseases
- Intervention (Device): Sham RIC
- Intervention (Device): Remote Ischemic Conditioning treatment instrument
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 157b415010ce28c1b80e8a2e9b52c783b48217e6c63c6653e4ffedd0c8029552
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
